Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

Europe - EPA:VIV - FR0000127771 - Common Stock

2.928 EUR
+0.01 (+0.21%)
Last: 11/17/2025, 5:06:39 PM
Fundamental Rating

2

Overall VIV gets a fundamental rating of 2 out of 10. We evaluated VIV against 45 industry peers in the Entertainment industry. VIV may be in some trouble as it scores bad on both profitability and health. VIV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year VIV has reported negative net income.
In the past year VIV had a positive cash flow from operations.
In multiple years VIV reported negative net income over the last 5 years.
Each year in the past 5 years VIV had a positive operating cash flow.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

VIV has a Return On Assets of -81.94%. This is amonst the worse of the industry: VIV underperforms 88.89% of its industry peers.
The Return On Equity of VIV (-124.64%) is worse than 73.33% of its industry peers.
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

The Gross Margin of VIV (28.96%) is worse than 80.00% of its industry peers.
In the last couple of years the Gross Margin of VIV has declined.
The Profit Margin and Operating Margin are not available for VIV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

3

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
VIV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, VIV has less shares outstanding
Compared to 1 year ago, VIV has a worse debt to assets ratio.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that VIV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VIV (1.32) is comparable to the rest of the industry.
VIV has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
The Debt to FCF ratio of VIV (1.38) is better than 80.00% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that VIV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.39, VIV is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Altman-Z 1.32
ROIC/WACCN/A
WACC6.21%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.51 indicates that VIV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.51, VIV is doing worse than 82.22% of the companies in the same industry.
VIV has a Quick Ratio of 0.51. This is a bad value and indicates that VIV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.51, VIV is doing worse than 82.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

0

3. Growth

3.1 Past

The earnings per share for VIV have decreased strongly by -1628.21% in the last year.
The Revenue has decreased by -4.81% in the past year.
Measured over the past years, VIV shows a very negative growth in Revenue. The Revenue has been decreasing by -54.89% on average per year.
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%

3.2 Future

VIV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.39% yearly.
The Revenue is expected to decrease by -66.28% on average over the next years. This is quite bad
EPS Next Y-55.21%
EPS Next 2Y-3.33%
EPS Next 3Y3.39%
EPS Next 5YN/A
Revenue Next Year-96.39%
Revenue Next 2Y-80.66%
Revenue Next 3Y-66.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VIV. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 26.52, VIV can be considered very expensive at the moment.
64.44% of the companies in the same industry are more expensive than VIV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VIV to the average of the S&P500 Index (34.59), we can say VIV is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 26.52
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

VIV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VIV is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.11
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.33%
EPS Next 3Y3.39%

2

5. Dividend

5.1 Amount

VIV has a Yearly Dividend Yield of 1.33%.
VIV's Dividend Yield is a higher than the industry average which is at 2.20.
With a Dividend Yield of 1.33, VIV pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

VIV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-0.67%
EPS Next 2Y-3.33%
EPS Next 3Y3.39%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

VIVENDI SE

EPA:VIV (11/17/2025, 5:06:39 PM)

2.928

+0.01 (+0.21%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-20 2025-10-20
Earnings (Next)03-04 2026-03-04/amc
Inst Owners31.09%
Inst Owner ChangeN/A
Ins Owners30.02%
Ins Owner ChangeN/A
Market Cap3.02B
Revenue(TTM)297.00M
Net Income(TTM)-6.00B
Analysts75.71
Price Target3.72 (27.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-0.67%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.69%
PT rev (3m)7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.16%
EPS NY rev (3m)-30.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.52
P/S 10.15
P/FCF 2.11
P/OCF 2.59
P/B 0.63
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.11
Fwd EY3.77%
FCF(TTM)1.39
FCFY47.49%
OCF(TTM)1.13
OCFY38.63%
SpS0.29
BVpS4.68
TBVpS4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -81.94%
ROE -124.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 482.16%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 1.38
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 89.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.32
F-Score4
WACC6.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.64%
EPS Next Y-55.21%
EPS Next 2Y-3.33%
EPS Next 3Y3.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-98.4%
Revenue Next Year-96.39%
Revenue Next 2Y-80.66%
Revenue Next 3Y-66.28%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.85%
EBIT Next 3Y27.57%
EBIT Next 5YN/A
FCF growth 1Y1178.57%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y133%
OCF growth 3Y3.97%
OCF growth 5Y7.73%

VIVENDI SE / VIV.PA FAQ

Can you provide the ChartMill fundamental rating for VIVENDI SE?

ChartMill assigns a fundamental rating of 2 / 10 to VIV.PA.


Can you provide the valuation status for VIVENDI SE?

ChartMill assigns a valuation rating of 3 / 10 to VIVENDI SE (VIV.PA). This can be considered as Overvalued.


How profitable is VIVENDI SE (VIV.PA) stock?

VIVENDI SE (VIV.PA) has a profitability rating of 1 / 10.


What is the financial health of VIVENDI SE (VIV.PA) stock?

The financial health rating of VIVENDI SE (VIV.PA) is 4 / 10.


What is the expected EPS growth for VIVENDI SE (VIV.PA) stock?

The Earnings per Share (EPS) of VIVENDI SE (VIV.PA) is expected to decline by -55.21% in the next year.